This year’s American Society of Hematology (ASH) 2018 Annual Meeting was held on December 1-4 in San Diego, California. Physicians, researchers, and health care professionals learned about the latest advances in the treatment of blood cancers and blood disorders. The meeting featured more than 4,400 abstracts, including over 1,000 presented at oral sessions. Many of the reported trials are expected to have an impact on clinical practice.
CheckRare was in attendance and provides some of the conference highlights, focusing on rare diseases.